Kriya Therapeutics

Please note: The information displayed on this page might be outdated.
Kriya Therapeutics: Developer of new gene therapies intended to address highly prevalent polygenic and non-genetic diseases. The company uses algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies, thereby enabling healthcare institutions to provide transformative new treatments for highly prevalent and severe chronic diseases.
/ Basic Materials/Forest Products
Based in...
US - Pacific
1100 Island Drive
Suite 203
Redwood City, CA 94065
United States

Company Participants at Spring Private Company Showcase

Shankar Ramaswamy, MD
Kriya Therapeutics, Co-Founder and CEO
Shankar Ramaswamy is a Co-Founder, Chairman, and Chief Executive Officer of Kriya. Dr. Ramaswamy was part of the early foundational team at Roivant Sciences, where he was responsible for helping to identify and evaluate assets across therapeutic areas and launch its first public subsidiary company. He went on to be the Chief Business Officer of Axovant Gene Therapies. Dr. Ramaswamy holds a medical degree from Brown University and an undergraduate degree in economics from Harvard University.